SCHEMBL2494467

SCHEMBL2494467

COc1ccc(CN(C)C)cc1C1(O)C(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.45
IDO1 P14902 2/20 0.44
CBX7 O95931 2/20 0.43
CDYL Q9Y232 2/20 0.43
CDYL2 Q8N8U2 1/20 0.43
CDY1; CDY1B Q9Y6F8 1/20 0.43
KCNQ3 O43525 1/20 0.41
KCNQ2 O43526 1/20 0.41
KCNQ4 P56696 1/20 0.41
KCNMA1 Q12791 1/20 0.41
KCNQ5 Q9NR82 1/20 0.41
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HTR7 P34969 2/20 0.38
HTR1A P08908 1/20 0.38
HTR1D P28221 1/20 0.38
HTR1B P28222 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR1E P28566 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2495393 0.87 KMT2A (0.57) KMT2AIDO1CBX7CDYLCDYL2
SCHEMBL2495110 0.83 KMT2A (0.48) KMT2AIDO1CBX7CDYLCDYL2
SCHEMBL2497604 0.82 KMT2A (0.51) KMT2AIDO1CBX7CDYLCDYL2
SCHEMBL2497429 0.82 CBX7 (0.52) KMT2AIDO1CBX7CDYLCDYL2
SCHEMBL5860255 0.81 KMT2A (0.50) KMT2AIDO1CBX7CDYLKCNQ3
SCHEMBL2499035 0.81 KMT2A (0.53) KMT2AIDO1CBX7CDYLCDYL2
SCHEMBL2496457 0.80 KMT2A (0.41) KMT2AIDO1CBX7CDYLCDYL2
SCHEMBL1464565 0.79 KMT2A (0.72) KMT2AIDO1CBX7CDYLCDYL2
SCHEMBL2495455 0.79 KCNQ3 (0.51) KMT2AIDO1CBX7CDYLCDYL2
SCHEMBL2495089 0.79 KMT2A (0.48) KMT2AIDO1CBX7CDYLCDYL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 KMT2A 1662/4885IDO1 4/4885CBX7 4226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.